Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Activation of the NOTCH pathway in head and neck cancer.
Defining the cellular role of TMCO1, a glaucoma-linked gene of unknown function
Selective shutoff of catabolite-sensitive host syntheses by bacroxyurea pharmaco mutation genes coliphages growth l virus replication escherichia coli growth l lysogeny crosses genetic coliteriophage N4.
Surrogate endpoints in head and neck cancer.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Surrogate endpoints in head and neck cancer.
Surrogate endpoints in head and neck cancer. Lancet Oncol. 2009 Apr; 10(4):309-10.
View in:
PubMed
subject areas
Biomarkers, Tumor
Combined Modality Therapy
Endpoint Determination
Head and Neck Neoplasms
Humans
Neoplasm Recurrence, Local
Survival Rate
authors with profiles
Ezra Cohen